Skip to content
10-Q

Quarterly Report

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

0001091818-25-000053

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 33.52M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $13.8K
Cash And Equivalents Q1 2025 · Dec 31, 2024 $862
Current Liabilities Q1 2025 · Mar 31, 2025 $275.04K
Current Liabilities Q1 2025 · Dec 31, 2024 $2.3M
Total Liabilities Q1 2025 · Mar 31, 2025 $275.04K
Total Liabilities Q1 2025 · Dec 31, 2024 $2.3M
Current Assets Q1 2025 · Mar 31, 2025 $13.8K
Current Assets Q1 2025 · Dec 31, 2024 $862
Total Assets Q1 2025 · Mar 31, 2025 $13.8K
Total Assets Q1 2025 · Dec 31, 2024 $862
Operating Income Q1 2025 · Mar 31, 2025 −$133.46K
Shares Diluted Q1 2025 · Mar 31, 2024 29.27M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$17.58K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$1.95M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$1.82M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.00
Eps Basic Q1 2025 · Mar 31, 2024 $0.00
Sga Expense Q1 2025 · Mar 31, 2024 $25.06K
Net Income Q1 2025 · Mar 31, 2024 −$130.81K